http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 26 Jul 2024 02:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Poolbeg+Pharma+PLC+Announces+Voluntary+Delisting+from+OTCQB+Market/23507676.html <p><strong>LONDON, UK / ACCESSWIRE / July 26, 2024 / </strong><a rel="nofollow" href="https://pr.report/11w9">Poolbeg Pharma</a> (AIM:POLB)(OTCQB:POLBF) 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that it is voluntarily delisting its ordinary shares ("Ordinary Shares") from trading on the OTCQB Market due to low trading volume and the associated administrative requirements. The Company's last day of trading on the OTCQB Market will be Monday 29 July 2024.</p><p>Poolbeg will retain its listing on the London Stock Exchange's AIM Market under its http://www.streetinsider.com/Press+Releases/Poolbeg+Pharma+PLC+Announces+Voluntary+Delisting+from+OTCQB+Market/23507676.html Fri, 26 Jul 2024 02:00:00 -0400 POLBF http://www.streetinsider.com/Accesswire/Poolbeg+Pharma+PLC+Announces+Voluntary+Delisting+from+OTCQB+Market/23507676.html <p><strong>LONDON, UK / ACCESSWIRE / July 26, 2024 / </strong><a rel="nofollow" href="https://pr.report/11w9">Poolbeg Pharma</a> (AIM:POLB)(OTCQB:POLBF) 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that it is voluntarily delisting its ordinary shares ("Ordinary Shares") from trading on the OTCQB Market due to low trading volume and the associated administrative requirements. The Company's last day of trading on the OTCQB Market will be Monday 29 July 2024.</p><p>Poolbeg will retain its listing on the London Stock Exchange's AIM Market under its http://www.streetinsider.com/Accesswire/Poolbeg+Pharma+PLC+Announces+Voluntary+Delisting+from+OTCQB+Market/23507676.html Fri, 26 Jul 2024 02:00:00 -0400 POLBF http://www.streetinsider.com/Press+Releases/Poolbeg+Pharma+PLC+Announces+Change+of+Registered+Address+/23423563.html <p><i><strong>Change of Registered Address</strong></i></p><p><strong>LONDON, UK / ACCESSWIRE / July 2, 2024 / </strong><a rel="nofollow" href="https://pr.report/ige">Poolbeg Pharma</a> (AIM:POLB)(OTCQB:POLBF), ('Poolbeg' or the 'Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that the Company has changed its registered address to 40 Bank Street, Floor 24, London, E14 5NR, United Kingdom.</p><p><strong>Enquiries</strong></p><table><tbody><tr><td style="height:15pt;padding:0cm;vertical-align:top;width:247.5pt;"><p style="margin-left:0cm;"><strong>Poolbeg Pharma Plc </strong><br />Jeremy Skillington, CEO <br />Ian O'Connell, CFO</p></td><td style="height:15pt;padding:0cm;vertical-align:top;width:216pt;"><p style="margin-left:0cm;text-align:right;">+44 (0) 207 183 1499</p></td></tr><tr><td style="height:15pt;padding:0cm;vertical-align:top;width:247.5pt;"><p style="margin-left:0cm;"><strong>Cavendish Capital Markets Ltd (Nominated Adviser & Joint Broker) </strong><br />Geoff Nash, Charlie Beeson, Nigel Birks, Harriet Ward (ECM)</p></td><td style="height:15pt;padding:0cm;vertical-align:top;width:216pt;"><p style="margin-left:0cm;text-align:right;">+44 http://www.streetinsider.com/Press+Releases/Poolbeg+Pharma+PLC+Announces+Change+of+Registered+Address+/23423563.html Tue, 02 Jul 2024 02:00:00 -0400 POLBF http://www.streetinsider.com/Accesswire/Poolbeg+Pharma+PLC+Announces+Change+of+Registered+Address+/23423563.html <p><i><strong>Change of Registered Address</strong></i></p><p><strong>LONDON, UK / ACCESSWIRE / July 2, 2024 / </strong><a rel="nofollow" href="https://pr.report/ige">Poolbeg Pharma</a> (AIM:POLB)(OTCQB:POLBF), ('Poolbeg' or the 'Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that the Company has changed its registered address to 40 Bank Street, Floor 24, London, E14 5NR, United Kingdom.</p><p><strong>Enquiries</strong></p><table><tbody><tr><td style="height:15pt;padding:0cm;vertical-align:top;width:247.5pt;"><p style="margin-left:0cm;"><strong>Poolbeg Pharma Plc </strong><br />Jeremy Skillington, CEO <br />Ian O'Connell, CFO</p></td><td style="height:15pt;padding:0cm;vertical-align:top;width:216pt;"><p style="margin-left:0cm;text-align:right;">+44 (0) 207 183 1499</p></td></tr><tr><td style="height:15pt;padding:0cm;vertical-align:top;width:247.5pt;"><p style="margin-left:0cm;"><strong>Cavendish Capital Markets Ltd (Nominated Adviser & Joint Broker) </strong><br />Geoff Nash, Charlie Beeson, Nigel Birks, Harriet Ward (ECM)</p></td><td style="height:15pt;padding:0cm;vertical-align:top;width:216pt;"><p style="margin-left:0cm;text-align:right;">+44 http://www.streetinsider.com/Accesswire/Poolbeg+Pharma+PLC+Announces+Change+of+Registered+Address+/23423563.html Tue, 02 Jul 2024 02:00:00 -0400 POLBF http://www.streetinsider.com/Press+Releases/Poolbeg+Pharma+PLC+Announces+Result+of+AGM/23363068.html <p><i><strong>Results of Annual General Meeting</strong></i></p> <p style="text-align:justify;"><strong id="dateline">LONDON, UNITED KINGDOM / ACCESSWIRE / June 17, 2024 / </strong> <a rel="nofollow" href="https://pr.report/5j6">Poolbeg Pharma</a> (AIM:POLB)(OTCQB:POLBF) ‘Poolbeg' or the ‘Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that all resolutions put to shareholders at the Company's Annual General Meeting held earlier today were duly passed.</p><p><strong>Enquiries</strong></p><table><tbody><tr><td style="height:15.0pt;padding:0cm;vertical-align:top;"><p><strong>Poolbeg Pharma Plc</strong></p><p>Jeremy Skillington, CEO</p><p>Ian O'Connell, CFO</p></td><td style="height:15.0pt;padding:0cm;vertical-align:top;"><p style="margin-left:60.0pt;">+44 (0) 207 183 1499</p></td></tr><tr><td style="height:15.0pt;padding:0cm;vertical-align:top;"><p><strong>Cavendish Capital Markets Ltd (Nominated Adviser & Joint Broker)</strong></p><p>Geoff Nash, Charlie Beeson, Nigel Birks, Harriet Ward (ECM)</p></td><td style="height:15.0pt;padding:0cm;vertical-align:top;"><p style="margin-left:60.0pt;">+44 (0) 207 220 0500</p></td></tr><tr><td http://www.streetinsider.com/Press+Releases/Poolbeg+Pharma+PLC+Announces+Result+of+AGM/23363068.html Mon, 17 Jun 2024 04:20:00 -0400 POLBF http://www.streetinsider.com/Accesswire/Poolbeg+Pharma+PLC+Announces+Result+of+AGM/23363068.html <p><i><strong>Results of Annual General Meeting</strong></i></p> <p style="text-align:justify;"><strong id="dateline">LONDON, UNITED KINGDOM / ACCESSWIRE / June 17, 2024 / </strong> <a rel="nofollow" href="https://pr.report/5j6">Poolbeg Pharma</a> (AIM:POLB)(OTCQB:POLBF) ‘Poolbeg' or the ‘Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that all resolutions put to shareholders at the Company's Annual General Meeting held earlier today were duly passed.</p><p><strong>Enquiries</strong></p><table><tbody><tr><td style="height:15.0pt;padding:0cm;vertical-align:top;"><p><strong>Poolbeg Pharma Plc</strong></p><p>Jeremy Skillington, CEO</p><p>Ian O'Connell, CFO</p></td><td style="height:15.0pt;padding:0cm;vertical-align:top;"><p style="margin-left:60.0pt;">+44 (0) 207 183 1499</p></td></tr><tr><td style="height:15.0pt;padding:0cm;vertical-align:top;"><p><strong>Cavendish Capital Markets Ltd (Nominated Adviser & Joint Broker)</strong></p><p>Geoff Nash, Charlie Beeson, Nigel Birks, Harriet Ward (ECM)</p></td><td style="height:15.0pt;padding:0cm;vertical-align:top;"><p style="margin-left:60.0pt;">+44 (0) 207 220 0500</p></td></tr><tr><td http://www.streetinsider.com/Accesswire/Poolbeg+Pharma+PLC+Announces+Result+of+AGM/23363068.html Mon, 17 Jun 2024 04:20:00 -0400 POLBF